Back
Sonnet BioTherapeutics Holdings 10K Form
Sell
33
SONN
Sonnet BioTherapeutics Holdings
Last Price:
1.88
Seasonality Move:
-15.89%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SONN News And Ratings
See the #1 stock for the next 7 days that we like better than SONN
SONN Financial Statistics
Sales & Book Value
| Annual Sales: | $147.81K |
|---|---|
| Cash Flow: | $-3.09M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.84 |
| Price / Book: | 2.29 |
Profitability
| EPS (TTM): | -12.75050 |
|---|---|
| Net Income (TTM): | $-14.46M |
| Gross Margin: | -- |
| Return on Equity: | -951.71% |
| Return on Assets: | -185.11% |
Sonnet BioTherapeutics Holdings Earnings Forecast
Key Sonnet BioTherapeutics Holdings Financial Ratios
- The Research & Development expenses have been 7,993.16% of Revenue.
- The Net Earning history of SONN is -12,741.15% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 3 years.
Sonnet BioTherapeutics Holdings Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SONN |
| Website: | sonnetbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.74 |
| Quick Ratio: | 1.21 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SONN Technical Analysis vs Fundamental Analysis
Sell
33
Sonnet BioTherapeutics Holdings (SONN)
is a Sell
Is Sonnet BioTherapeutics Holdings a Buy or a Sell?
-
Sonnet BioTherapeutics Holdings stock is rated a Sell
The current Sonnet BioTherapeutics Holdings [SONN] share price is $1.92. The Score for SONN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.